Early use of levosimendan to improve survival and neurological outcomes after cardiac arrest with myocardial dysfunction: a protocol for a randomized controlled trial
Zhen De, Nengyuan Xu, Hua Zhang, Fan Yang, Lanfang Du · 2026
Read Early use of levosimendan to improve survival and neurological outcomes after cardiac arrest with myocardial dysfunction: a protocol for a randomized controlled trial by Zhen De, Nengyuan Xu, Hua Zhang, Fan Yang, Lanfang Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13627038.txt.
Description
Zhen De, Nengyuan Xu, Hua Zhang, Fan Yang, and Lanfang Du present a trial protocol from two thousand twenty-six. The trial tests a heart drug given early after cardiac arrest. Many patients whose hearts restart still have weak heart muscle, and that weakness is a major cause of early death.
The plan enrolls sixty patients in a coma at three centers in China. Half will get the drug by vein for a day, and half will get salt water instead. Treatment starts within hours after the heart restarts. The main check is death within thirty days, with brain recovery and heart strength also tracked during the first week.
Catalog record
| CREATOR | Zhen De, Nengyuan Xu, Hua Zhang, Fan Yang, Lanfang Du |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |